Wang, Xu-Wen http://orcid.org/0000-0001-7670-3544
Madeddu, Lorenzo
Spirohn, Kerstin http://orcid.org/0000-0002-2071-1606
Martini, Leonardo
Fazzone, Adriano http://orcid.org/0000-0002-3062-4485
Becchetti, Luca
Wytock, Thomas P. http://orcid.org/0000-0001-5204-1064
Kovács, István A.
Balogh, Olivér M. http://orcid.org/0000-0002-6296-6383
Benczik, Bettina
Pétervári, Mátyás
Ágg, Bence http://orcid.org/0000-0002-6492-0426
Ferdinandy, Péter
Vulliard, Loan http://orcid.org/0000-0002-2260-4935
Menche, Jörg http://orcid.org/0000-0002-1583-6404
Colonnese, Stefania
Petti, Manuela http://orcid.org/0000-0002-0149-161X
Scarano, Gaetano http://orcid.org/0000-0002-1120-707X
Cuomo, Francesca
Hao, Tong http://orcid.org/0000-0001-7908-3256
Laval, Florent http://orcid.org/0000-0001-7744-6199
Willems, Luc
Twizere, Jean-Claude http://orcid.org/0000-0002-8683-705X
Vidal, Marc
Calderwood, Michael A. http://orcid.org/0000-0001-6475-1418
Petrillo, Enrico http://orcid.org/0000-0002-9119-5434
Barabási, Albert-László
Silverman, Edwin K.
Loscalzo, Joseph http://orcid.org/0000-0002-1153-8047
Velardi, Paola
Liu, Yang-Yu http://orcid.org/0000-0003-2728-4907
Article History
Received: 24 February 2022
Accepted: 2 March 2023
First Online: 22 March 2023
Competing interests
: PF is the founder and CEO of Pharmahungary Group, a group of R&D companies. EKS has received institutional grant support from Bayer and GlaxoSimthKline. A-LB is co-scientific founder of and is supported by Scipher Medicine, Inc., which applies network medicine strategies to biomarker development and personalized drug selection, and is the founder of Naring Inc., which applies data science to health and nutrition. The remaining authors declare no competing interests.